These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13362864)

  • 1. Resistance of tubercle bacilli to pyrazinamide in vivo.
    LEE SH; MCCUNE RM; MCDERMOTT W; TOMPSETT R; WASZ-HOCKERT O
    Am Rev Tuberc; 1956 Oct; 74(4):572-80. PubMed ID: 13362864
    [No Abstract]   [Full Text] [Related]  

  • 2. Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid.
    STEWART SM; MURDOCH JM; CROFTON JW; HAY D
    Br J Tuberc Dis Chest; 1957 Apr; 51(2):158-67. PubMed ID: 13413200
    [No Abstract]   [Full Text] [Related]  

  • 3. The pyrazinamide susceptibility of isoniazid-resistant mutants of tubercle bacilli.
    PERRY CR; MORSE WC
    Am Rev Tuberc; 1955 Dec; 72(6):840-2. PubMed ID: 13268854
    [No Abstract]   [Full Text] [Related]  

  • 4. A method for the determination of in vitro sensitivity of tubercle bacilli to pyrazinamide (aldinamide).
    DESSAU FI; BURGER F; YEAGER RL; KULISH M
    Am Rev Tuberc; 1952 May; 65(5):635-6. PubMed ID: 14924185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistance of tubercle bacilli to isonicotinic hydrazide].
    RIST N
    Presse Med (1893); 1952 May; 60(37):806-7. PubMed ID: 14957832
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of isonicotinic acid hydrazide (isoniazid) on survival time of mice infected with tubercle bacilli resistant to the drug in vitro.
    KARLSON AG; IKEMI Y
    Proc Staff Meet Mayo Clin; 1952 Sep; 27(19):373-6. PubMed ID: 14957895
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vivo studies of effect of isonicotinic acid hydrazide on tubercle bacilli].
    BEKIERKUNST A; SZULGA T
    Pol Tyg Lek (Wars); 1952 Dec; 7(51-52):1761-3. PubMed ID: 13047085
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of isonicotinic acid derivatives on tubercle bacilli.
    ARONSON JD; EHRLICH SL; FLAGG W
    Proc Soc Exp Biol Med; 1952 Jun; 80(2):259-62. PubMed ID: 14949016
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of tubercle bacilli in raising the nicotinic acid level in the blood.
    EL RIDI MS; ABDEL KADER MM; HABIB A; ABDEL AZIZ A
    J Egypt Med Assoc; 1953; 36(8):435-44. PubMed ID: 13130774
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of isoniazid (isonicotinic acid hydrazide) on intracellular tubercle bacilli.
    MACKANESS GB; SMITH N
    Am Rev Tuberc; 1952 Aug; 66(2):125-33. PubMed ID: 14943921
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of increased drug resistance of tubercle bacilli from patients treated with hydrazines of isonicotinic acid.
    STEENKEN W; MEADE GM; WOLINSKY E; COATES EO
    Am Rev Tuberc; 1952 Jun; 65(6):754-8. PubMed ID: 14924198
    [No Abstract]   [Full Text] [Related]  

  • 12. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli in the tissues despite prolonged antimicrobial therapy.
    MCCUNE RM; TOMPSETT R
    J Exp Med; 1956 Nov; 104(5):737-62. PubMed ID: 13367341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenicity of isoniazid-resistant tubercle bacilli and prophylaxis of tuberculosis in children.
    RIST N
    Am Rev Tuberc; 1956 Aug; 74(2 Part 2):75-89; discussion, 90-9. PubMed ID: 13340168
    [No Abstract]   [Full Text] [Related]  

  • 14. The virulence of isoniazid resistant tubercle bacilli, recovered from patients during treatment.
    MEISSNER G
    Dis Chest; 1954 Jul; 26(1):15-26. PubMed ID: 13173335
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the virulence of chemoresistant tubercle bacilli. II. Tubercle bacilli which have become resistant to isoniazid in vivo].
    MEISSNER G
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1954; 110(6):538-46. PubMed ID: 13159801
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiplication of tubercle bacilli within phagocytes cultivated in vitro, and effect of streptomycin and isonicotinic acid hydrazide.
    SUTER E
    Am Rev Tuberc; 1952 Jun; 65(6):775-6. PubMed ID: 14924204
    [No Abstract]   [Full Text] [Related]  

  • 17. Sterilization of tubercle bacilli by isonicotinic acid hydrazide and the incidence of variants resistant to the drug in vitro.
    MIDDLEBROOK G
    Am Rev Tuberc; 1952 Jun; 65(6):765-7. PubMed ID: 14924201
    [No Abstract]   [Full Text] [Related]  

  • 18. Attenuation of highly isoniazid-resistant tubercle bacilli.
    HIRANO N; NAKANISHI K; FUKUNAGA K
    Yokohama Med Bull; 1955 Aug; 6(4):196-202. PubMed ID: 13300158
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental studies on chemotherapy of tuberculosis. II. Problem of virulence changes of tubercle bacilli after prolonged chemotherapeutic treatment].
    VELTMAN G
    Zentralbl Bakteriol Orig; 1955 Jun; 163(2-3):210-8. PubMed ID: 13257661
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility to isoniazid and pathogenicity of tubercle bacilli.
    BLOCH H; WIDELOCK D; PEIZER LR
    Am Rev Tuberc; 1953 Nov; 68(5):734-8. PubMed ID: 13104886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.